Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Dérivé de l'échinocandine")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 461

  • Page / 19
Export

Selection :

  • and

Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin TreatmentDESNOS-OLLIVIER, Marie; MOQUET, Olivier; CHOUAKI, Taieb et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 6, pp 2304-2306, issn 0095-1137, 3 p.Article

Breakthrough invasive mould infections in patients treated with caspofunginPHAI PANG, Katy-Anna; GODET, Cendrine; DATRY, Annick et al.The Journal of infection. 2012, Vol 64, Num 4, pp 424-429, issn 0163-4453, 6 p.Article

Caspofungin Disk Diffusion Breakpoints and Quality ControlBROWN, Steven D; TRACZEWSKI, Maria M.Journal of clinical microbiology (Print). 2008, Vol 46, Num 6, pp 1927-1929, issn 0095-1137, 3 p.Article

Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective ConcentrationFULLER, Jeff; SCHOFIELD, Adam; JIWA, Safeer et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 2, pp 479-482, issn 0095-1137, 4 p.Article

Caspofungin Affects Growth of Paracoccidioides brasiliensis in Both Morphological PhasesRODRIGUEZ-BRITO, Sabrina; NINO-VEGA, Gustavo; SAN-BLAS, Gioconda et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5391-5394, issn 0066-4804, 4 p.Article

Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with CaspofunginSUAREZ, Felipe; OLIVIER, Gaelle; GARCIA-HERMOSO, Dea et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 1, pp 461-465, issn 0095-1137, 5 p.Article

Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofunginELEONORA MILICI, Maria; MASSIMO MAIDA, Carmelo; SPREGHINI, Elisabetta et al.Journal of clinical microbiology (Print). 2007, Vol 45, Num 11, pp 3529-3533, issn 0095-1137, 5 p.Article

Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal AgentsVAN DE SANDE, Wendy W. J; FAHAL, Ahmed H; BAKKER-WOUDENBERG, Irma A. J. M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2738-2740, issn 0066-4804, 3 p.Article

Profiling the Aspergillus fumigatus Proteome in Response to CaspofunginCAGAS, Steven E; RAJA JAIN, Mohit; HONG LI et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 1, pp 146-154, issn 0066-4804, 9 p.Article

Prise en charge des candidoses et aspergilloses invasives. Actualités sur la caspofungineLa Lettre de l'infectiologue. 2008, Num MARS, issn 0296-9009, 7 p., HSSerial Issue

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic FailureLEWIS, James S; WIEDERHOLD, Nathan P; WICKES, Brian L et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4559-4561, issn 0066-4804, 3 p.Article

Stepwise Development of a Homozygous S80P Substitution in Fkslp, Conferring Echinocandin Resistance in Candida tropicalisJENSEN, Rasmus Hare; JOHANSEN, Helle Krogh; ARENDRUP, Maiken Cavling et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 614-617, issn 0066-4804, 4 p.Article

Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin ResistanceKATIYAR, Santosh K; ALASTRUEY-IZQUIERDO, Ana; HEALEY, Kelley R et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 12, pp 6304-6309, issn 0066-4804, 6 p.Article

Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric PatientsLI, Chi-Chung; PENG SUN; YINGWEN DONG et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 5, pp 2098-2105, issn 0066-4804, 8 p.Article

Susceptibility of Pneumocystis to Echinocandins in Suspension and Biofilm CulturesCUSHION, Melanie T; COLLINS, Margaret S.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 10, pp 4513-4518, issn 0066-4804, 6 p.Article

Caspofungine = CaspofunginLANTERNIER, F; LORTHOLARY, O.Journal de mycologie médicale. 2010, Vol 20, Num 3, pp 190-193, issn 1156-5233, 4 p.Article

Differential Aspergillus lentulus Echinocandin Susceptibilities Are Fksp IndependentSTAAB, Janet F; NIELSEN KAHN, Jennifer; MARR, Kieren A et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 4992-4998, issn 0066-4804, 7 p.Article

Caspofungin for the Treatment of Pediatric Fungal InfectionsFISHER, Brian T; ZAOUTIS, Theoklis.The Pediatric infectious disease journal. 2008, Vol 27, Num 12, pp 1099-1101, issn 0891-3668, 3 p.Article

Nouveaux antifongiques systémiques = New antifungalsCAZENAVE, B; LANTERNIER, F; LORTHOLARY, O et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 5, pp 178-184, issn 0296-9009, 7 p.Article

Role for Fksl in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiaeKATIYAR, Santosh K; EDLIND, Thomas D.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 1772-1778, issn 0066-4804, 7 p.Article

Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutationsBOURGEOIS, N; LAURENS, C; BERTOUT, S et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 7, pp 1247-1252, issn 0934-9723, 6 p.Article

Generation of Mutants in Candida albicans with Reduced Susceptibility to Caspofungin: Influence on Other Antifungal ProductsSOLER, L; RODRIGUEZ, J. C; BELDA, S et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 4, pp 283-284, issn 1120-009X, 2 p.Article

Comparison of Caspofungin MICs by Means of EUCAST Method EDef 7.1 Using Two Different Concentrations of GlucoseRODRIGUEZ-TUDELA, Juan Luis; GOMEZ-LOPEZ, Alicia; ARENDRUP, Maiken C et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 7, pp 3056-3057, issn 0066-4804, 2 p.Article

Paradoxical Growth of Candida dubliniensis Does Not Preclude In Vivo Response to Echinocandin TherapyMARINE, Marçal; JAVIER PASTOR, F; SAHAND, Ismail H et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 12, pp 5297-5299, issn 0066-4804, 3 p.Article

Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infectionsDINUBILE, M. J; STROHMAIER, K. M; LUPINACCI, R. J et al.European journal of clinical microbiology & infectious diseases (Print). 2008, Vol 27, Num 8, pp 663-670, issn 0934-9723, 8 p.Article

  • Page / 19